Clinical evidence demonstrates an inverse relationship between circulating adiponectin levels and depression, with lower concentrations associated not only with disease presence but also with greater symptom severity, suggesting a potential causal role for this adipokine in depressive pathophysiology [100,101,102,103]. Here, ADIPOQ is linked to depressive symptom measurement.